Abstract
We developed a novel cysteine sulfinic acid decarboxylase knockout mouse (CSAD KO) to investigate the critical roles of taurine. The absence of the CSAD gene was confirmed using Southern, northern and western blotting; homozygous (CSAD−/−) and heterozygous (CSAD+/-) animals were identified using PCR. Plasma taurine concentrations were decreased by 86 % in CSAD−/− animals. Reproductive performance was poor in the second and later CSAD−/− generations but was restored by supplementing the drinking water with 0.05 % taurine. Taurine concentrations at postnatal day 1 (PD1) in generation 1 (G1) CSAD−/− were close to normal presumably due to taurine transport through the placenta from the CSAD+/− dam. In contrast, taurine concentrations in the brain and liver of G2, G3, and G4 CSAD−/− were very low at birth. At 1 month of age (1 M), 1 week after weaning, the G1 CSAD−/− taurine concentration in the liver decreased to the same level as G2, G3, and G4 CSAD−/−. Taurine concentrations in all CSAD−/− at 1 M were reduced to 44 % of WT in the brain and 5 % in the liver. Taurine supplementation restored brain levels to 76 % of WT but had little effect on the liver. Gene expression in CSAD−/− brain and liver was compared to WT at PD1 and 1 M. Expression of the prolactin receptor and lactoferrin genes was decreased in CSAD−/− at both PD1 and 1 M. Metabolic genes including serine dehydratase and uridine phosphorylase 2 were increased significantly at PD1 but not at 1 M. An oxidative stress gene, glutathioneperoxidase 3 was increased in CSAD KO−/− at both PD1 and 1 M. Expression of taurine metabolism genes, cysteine dioxygenase (Cdo), cysteamine dioxygenase and the taurine transporter (TauT) were unaffected at PD1. At 1 M, however, TauT in CSAD−/− liver was increased twofold, while Cdo was decreased compared to WT. These data indicate that the CSAD KO mouse is a powerful model for exploring the role of taurine deficiency in various disorders especially since the requirement for taurine can be supplied in food or water.
Access provided by Autonomous University of Puebla. Download conference paper PDF
Similar content being viewed by others
Keywords
- Taurine
- Cysteine sulfinic acid decarboxylase knockout mice
- Taurine concentrations
- Newborn pups
- Weanling mice
- RT2 qPCR
1 Introduction
The essential physiological functions of taurine in development of the brain and eye, in reproduction, endocrine regulation, kidney and cardiovascular function, membrane stabilization, osmotic regulation as well as immune function have been well documented in many laboratories (Schuller-Levis and Park 2006; Sturman 1993). Four gene products are critical to taurine homeostasis: cysteine dioxygenase (CDO; EC 1.13.11) oxidizes cysteine to cysteine sulfinic acid which is converted to hypotaurine which is then oxidized to taurine (Stipanuk 2004; Bella et al. 2000; Hosokawa et al. 1990); cysteamine dioxygenase ADO (EC1.13.11.19) which is converted cysteamine to hypotaurine (Dominy et al. 2007); the taurine transporter (TauT) (Uchida et al. 1992); and cysteine sulfinic acid decarboxylase, CSAD (EC 4.1.1.29), which is the enzyme that converts cysteine sulfinic acid to hypotaurine (Park et al. 2002).
Taurine is considered a conditionally essential amino acid in humans and primates and is required during their development. Taurine deficient animals are useful in investigations of taurine’s physiological functions because it is possible to study both taurine deficiency itself and the effect of supplementation with taurine in food or drinking water. Cats and rodents have been used as animal models for taurine studies because their taurine levels could be easily manipulated (Sturman 1993; Sturman and Messing 1991, 1992). Cats have been used for taurine studies because they produce only low levels of CDO and CSAD leading to a dependence on dietary sources of taurine. However, the cat model has limitations including a long gestation period, a heterogeneous genetic background and a relatively large maintenance expense and the absence of genetic, molecular and immunological reagents. Rodents have high levels of CSAD (Schuller-Levis and Park 2006; Sturman 1993; Huxtable 2000) and taurine is not essential to their diet. Due to high concentrations of taurine in rodents, competitive inhibitors of taurine transport including guanidinoethanesulfonate (GES) or β-alanine have been used to produce taurine deficiency (Bonhaous et al. 1985; Dela Rosa and Stipanuk 1984; Jong et al. 2010). However, these chemicals have toxic side effects.
Recently genetically modified mice have been developed to model taurine deficiency using gene targeting methods. These taurine-deficient knock-out mice include taurine transporter knockout mice (TauT KO) and cysteine dioxygenase knockout mice (CDO KO). Two TauT KO mouse models show reduced levels of taurine in various tissues including heart, brain, muscle, kidney and liver (Heller-Stilb et al. 2002; Warsulat et al. 2007; Ito et al. 2008). These TauT KO models demonstrate developmental effects in various organs including the retina, liver, brain, muscle and heart. A cysteine dioxygenase deficient (CDO KO) model was produced by deleting CDO, thereby disabling the production of cysteine sulfinic acid, a substrate for CSAD, from cysteine (Ueki et al. 2011, 2012; Roman et al. 2013). These mice have severe taurine deficiency and increased catabolism of cysteine to hydrogen sulfide, which leads to pulmonary and pancreatic toxicity.
Recently, our laboratory produced a cysteine sulfinic acid decarboxylase knockout mouse (CSAD KO) as a novel mouse model of taurine deficiency (Park et al. 2014). CSAD is an enzyme for taurine biosynthesis and a cytosolic enzyme expressed primarily in liver and kidney (Sturman 1993; Park et al. 2002). The level of CSAD activity determines the need for dietary taurine. Our laboratory demonstrated high neonatal mortality in the third and fourth generation of CSAD−/− homozygotes (G3 HO and G4 HO) and restoration of neonatal survival by the addition of 0.05 % taurine added to the drinking water. Compared to wild type (WT), taurine concentrations in the liver and brains of newborn pups are significantly lower except in G1 HO, which are born from CSAD+/− heterozygous (HT) dams which have near normal levels of serum taurine. Low taurine concentrations in the liver and brain in HOs are significantly restored by supplementation of taurine in the drinking water of the dam. Gene expression of prolactin receptor (Prlr) and lactoferrin (ltf) is decreased but gene expression of glutathione peroxidase 3 (Gpx 3) and peroxireductase (Prx 2) increased, suggesting oxidative stress may be involved in neonatal mortality. Here we compare these phenotypic changes in newborn pups and weanling mice.
2 Materials and Methods
2.1 Materials
Chemicals used in this study were purchased from Sigma Chemicals (St. Louise, MO) if not otherwise noted. Oligonucleotide primers for PCR for genotype were obtained from Eurofins MWG Operon (Huntsville, AL). Primers were designed by Primer Designer 4 (Scientific and Educational Software, Cary, NC). Taq polymerase and deoxynucleotides were purchased from New England Biolabs (Ipswich, MA). Agarose was obtained from Lonza Group LTD (Rockland, ME). Trizol and RNeasy kit for RNA extraction were obtained from Invitrogen and Qiagen (Valencia, CA), respectively. The SYBR master mix and primers used in RT2 qPCR were purchased from Qiagen.
2.2 CSAD KO Mice
CSAD KO mice were produced previously described from our laboratory (Park et al. 2014). Briefly, chimeric CSAD KO mice were produced by injection of cells from a gene trap ES cell line (XP0392) into C57BL/6 (B6) blastocysts at the Mouse Mutant Regional Resource Centers (MMRRC, UC Davis, CA) which were implanted into a pseudopregnant B6 mouse. Chimeric mice from MMRRC were mated with B6 (Jackson Laboratories, Bar Harbor, ME) in the animal colony at NYS Institute for Basic Research in Developmental Disabilities. Heterozygous siblings were mated to produce CSAD−/− homozygous pups (HO). Experimental mice were fed taurine-free chow (LabDietR, PMI Nutrition International, St. Louis, MO). Taurine concentrations in commercial food were confirmed by HPLC. All mice were kept under 12-h day/night with free access to food and water. Some experimental animals had exogenous taurine added to their water at 0.05 % as indicated in Results. For optimum reproductive performance, one or two females were mated to a single male. Both females and males used for mating in the taurine-treated groups were supplemented with taurine. Animals were weaned at 3 weeks of age. All mice at 1 M used in this study were separated from their dam for 1 week. All procedures involving live animals were approved by the Institutional Animal Care and Use Committee of IBR.
2.3 High Performance Liquid Chromatography (HPLC)
The liver and brain as well as plasma were obtained from all groups including WT and HT as well as G1 HO, G2 HO, G3 HO and G4 HO at birth (PD1) and 1 month of age (1M) after mice were injected ip with avertine (250 mg/Kg). These samples were also collected from the taurine-treated groups including G2 HOT, G3 HOT and G4 HOT. Taurine concentrations were determined using HPLC (Waters, Milford, MA) (Battaglia et al. 1999). Briefly, tissues and plasma were homogenized using 5 % TCA and centrifuged for removal of proteins. After samples were dried using a Speedvac (Savant, Holbrook, NY), they were derivatized using phenylisothiocyanate (PITC) and separated using a C18 column with a gradient of acetate buffer containing 2.5 % acetonitrile (pH 6.5) and 45 % acetonitrile solution containing 15 % methanol at 45 °C. The flow rate was 1 ml/min. Taurine concentrations were determined by comparison to a standard.
2.4 RT2 qPCR Analysis
Total RNA was extracted using RNeasy kit (Qiagen) from the liver and was reverse-transcribed using cDNA kit according to the manufacturer’s instruction (Qiagen). Quantitative real time PCR with 10 ng of cDNA were carried out in duplicate in a 7300 real-time PCR system (Eppendorff, Hauppauge, NY) using the SYBR master mix (Qiagen) and the following cycles: 2 min at 50 °C, 10 min at 95 °C and 40 cycles each at 95 °C for 15 s and 60 °C for 60 s (Park et al. 2014). RT2 qPCR analysis was also carried out according to manufacturer’s manual using β-actin as a control. All primers were purchased from Qiagen. For data analysis the Ct method was used; for each gene fold-changes were calculated as difference in gene expression of G3 HO and G3 HOT, compared to that in WT. ∆Ct was calculated by subtraction of Ct of β-actin from Ct of the interesting gene. ∆∆Ct was calculated by subtraction of ∆Ct of WT from ∆Ct of G3 HO or H3 HOT. Fold change was determined by 2(-ΔΔCt). More than 1 indicates gene up-regulation and less than 1 indicates gene down-regulation.
2.5 Statistical Analysis
Data are presented as mean + SE. Statistical significance was determined using Statistica 8 (StatSoft, Tulsa, OK). Significant differences between groups were determined as p < 0.05 using LSD or Tukey HSD in post-hoc under one way ANOVA or t-test.
3 Results
3.1 Taurine Concentrations in the Brain, Liver and Plasma at 1 Month of Age in CSAD KO
We used HPLC to measure taurine concentrations in the liver and brain as well as plasma because the liver is a major organ for taurine production by CSAD while the brain requires taurine. Plasma taurine was measured because the vascular system supplies the taurine required by various organs.
Inactivation of one CSAD allele did affect taurine levels at 1 M: Although brain and plasma taurine concentrations in CSAD+/− were not decreased significantly, liver taurine concentrations were decreased to 77 % of wild type (WT). Previously, we demonstrated that G1 CSAD−/− born from CSAD+/− dams show higher taurine concentrations in the liver and brain compared to G2, G3 and G4 CSAD−/−, presumably because of taurine transported through the placenta (Grillo et al. 2008). However, taurine concentrations in the liver, brain and plasma of G1 CSAD−/− at 1 M of age (1 week after weaning) fell to the same levels as in G2, G3 and G4 CSAD−/− (Figs. 1, 2 and 3).
While taurine concentrations in the liver from all generations of CSAD−/− were decreased to approximately 5 % of WT level at 1 M, taurine concentrations in the brain of CSAD−/− decreased to 40 % of WT. Supplementation with 0.05 % taurine in the drinking water brought liver and brain taurine concentrations to 10 and 76 % of wild type (WT), respectively. Thus, while brain taurine concentrations in CSAD−/− treated with taurine (HOT) were significantly increased, liver taurine concentrations were not. At PD1, G3 and G4 HOT taurine concentrations were significantly increased in both brain and liver.
Plasma concentrations in all generations of CSAD−/− were decreased to less than 14 % of WT and were restored to 65 % of WT with taurine supplementation in the drinking water compared to WT (Fig. 3). Females and males in all groups were not significantly different in taurine concentrations in brain, liver or plasma.
3.2 Gene Expression Measured Using RT2 qPCR
We examined gene expression in CSAD KO liver using a microarray analysis. This specifically focused on genes that were candidates for influencing neonatal mortality, genes related to taurine metabolism and transport, genes for anti-oxidant enzymes, nucleotide and amino acid metabolic enzymes as well as for lactoferrin and the prolactin receptor. Taurine-related genes included CSAD, CDO, cysteamine dioxygenase (ADO) and TauT (Table 1). In contrast to gene expression at PD1, CDO was significantly decreased and TauT was significantly increased more than twofold at 1 M in G3 HO. CDO was restored in G3 HOT whereas TauT was not significantly different in G3 HOT compared to G3 HO. As expected, no CSAD expression was detected at PD1 and 1 M. ADO at both PD1 and 1 M was unaffected in both G3 HO and G3 HOT compared to WT.
Since taurine is an antioxidant we examined the expression of genes for antioxidant enzymes included glutathione peroxidase 1 and 3 (Gpx 2 and 3) as well as peroxireductase 2 (Prdx 2) (Table 2). Gpx 3 in G3 HO at 1 M was significantly increased more than twice that of WT just as it had been at PD1. However, Gpx 1 and Prdx 2 in G3 HO were not changed at 1 M even though Gpx 1 had been increased at PD1. Taurine supplementation restored Gpx 3 in G3 HOT to WT level at 1 M. While both uridine dephosphorylase 2 (Upp 2), a nucleotide metabolic enzyme, and serine hydratase (Sds), a amino acid metabolic enzyme, in G3 HO at PD1 were increased significantly, Upp 2 and Sds in G3 HO at 1 M were not different compared to WT (Table 3). Taurine treatment decreased Upp2 and Sds expression significantly in G3 HOT. Ltf and Prlr were significantly decreased in G3 HO at 1 M, as they had been a PD1. However, taurine treatment restored both at 1 M while only Prlr was restored at PD1.
4 Discussion
Weanling CSAD KO at 1 M showed a profile of taurine distribution in the liver and brain (Fig. 1, 2, and 3) that was different from the profile at PD1 (Park et al. 2014). At PD1, taurine concentrations in both the brain and liver from G2 and G3 HO were approximately 80 % lower than WT. Taurine-treated G2 and G3 HO dams had pups with PD1 liver and brain taurine concentrations that were substantially and similarly increased. However, at 1 M, taurine concentrations in the HO brain were a higher percentage of WT than in the liver (Figs. 1 and 2). After taurine treatment, CSAD−/− liver taurine was significantly less at 1 M than at PD1 despite the increase in liver TauT gene expression (Table 1). In contrast treatment substantially restored taurine levels in the brain at 1 M. Plasma taurine was increased significantly (p < 0.001) to approximately 65 % of WT level in the taurine-supplemented CSAD−/− mice (Fig. 3). Taurine concentrations were significantly increased in the brain of these mice but not in the liver which suggests that because the brain is not a major biosynthetic source of taurine, it may be better equipped to utilize the taurine supplied though the drinking water than the liver is. This suggests that when taurine is required for physiological function, taurine may be actively transported from the circulatory system to the organ(s) via TauT. Taurine concentrations in the splenocytes from G3 HO were decreased 56 % compared to WT, similar to the brain (data not published).
These results were similar to those in taurine-deficient knockout mouse models and in cats (Sturman 1993). Taurine concentrations in the liver from CDO KO and TauT KO are significantly decreased (Heller-Stilb et al. 2002; Ito et al. 2008; Ueki et al. 2011). However, in our study taurine concentrations in the liver and brains from females and males in all groups were not significantly different although taurine concentrations in CDO KO females were higher than in males. Physical phenotypes observed in CDO KO (excess lacrimation and partial palpebral closure, plantigrade stance, hyperextensible toes and less-erect ears) were not observed in CSAD KO. Although neonatal mortality was detected in G3 and G4 HO, surviving CSAD KO grew normally without weight loss compared to WT. However, CDO KO weight and size is less than WT. Taurine deficiency in the cat is similar to CSAD KO with respect to taurine levels. Taurine concentrations in the liver from adult cats without taurine treatment were remarkably decreased compared to adult cats fed 0.05 % taurine. However, the developmental defects in surviving offspring from female taurine-deficient cats such as hind leg development and a peculiar gait characterized by excessive abduction and paresis, were not detected in CSAD KO (Sturman 1993).
CSAD−/− gene expression at 1 M is also unlike PD1. CDO in the liver from G3 HO was significantly increased due to feedback inhibition (accumulation of CSAD in CSAD KO) (Table 1). TauT expression in the liver of G3 HO and G3 HOT was also increased compared to WT at 1 M but not at PD1, indicating TauT may facilitate taurine transport to compensate for decreased taurine concentrations. CSAD gene expression was absent in both groups at both PD1 and 1 M, confirming deletion of the CSAD. The antioxidant enzyme, Gpx 3 expression was increased at 1 M although both Gpx 1 and 3 expression were increased at PD1 (Schaffer et al. 2009; Brigelius-Flohe and Maiorino 2013; Lubos et al. 2011). Alteration in these genes may contribute to neonatal death at PD1. Although G3 HO thrived, antioxidant enzymes may be needed for survival because mice are under oxidative stress due to taurine deficiency. Gpx 3 expression was restored in G3 HOT suggesting taurine may be an antioxidant. Since newborn G3 CSAD−/− often lacked milk spots (MS), a predictor of survival in newborn mice, we examined the gene expression of Ltf and Prlr. Ltf has innate immune function to protect newborn offspring from infection and is elevated in colostrum (Ward and conneely 2004; Legrand and Mazurier 2010; Legrand 2012). Ltf is widely present in fluids such as milk and colostrum with a high affinity for iron. Lft, an important component of the innate immune system, is important in bacteriostasis and required for optimal neutrophil function. Prolactin, a lactogenic hormone, regulates the output of insulin-like growth factor-1. Genetic ablation of Prlr results in mice which show multiple defects in reproduction leading to infertility, altered maternal behavior and reduced bone development (Brooks 2012; Binart et al. 2010; Bole-Feysot et al. 1998). Of importance, Ltf and Prlr in the liver were decreased significantly in G3 HO but only Prlr was restored by taurine-supplementation (G3 HOT) (Fig. 4) at PD1. However, at 1 M, both Prlr and Ltf were decreased significantly compared to WT and restored to WT with added taurine, suggesting these genes may be down-regulated by low taurine concentrations. Upp 2 catalyzes the cleavage of uridine to uracil and ribose and used both energy sources and nucleotide synthesis (Roosild et al. 2011; Wan et al. 2010; Johansson 2003). Serine is a substrate for Sds with production of the two products, pyruvate (precursor of glucose) and NH3 for gluconeogenesis from amino acids (Masuda et al. 2003; Imai et al. 2003; Lopez-Flores et al. 2006) The significant increase of Upp 2 and Sds in G3 HO without MS is unclear but may show the critical regulation of physiological processes by uridine or may be due to starvation (Ishikawa et al. 1965). However, Upp2 and Sds in the liver from G3 HO at 1 M were not changed although expression of these two enzymes in the liver from G3 HO without MS at PD1 is dramatically increased. With taurine supplementation both genes were significantly decreased, suggesting taurine may be involved in regulation of nucleotide metabolism and gluconeogenesis.
Alteration of gene expression in CSAD KO was similar to that in other models of taurine deficiency. Gene expression in CDO KO was altered compared to WT. Expression of CSAD gene in CDO KO was increased significantly compared to WT and expression of ADO gene in CDO KO was without effect similar to CSAD KO. Although an increase of TauT in CDO KO was consistent with that in CSAD KO, TauT in taurine-treated CDO KO was restored to WT (Roman et al. 2013) but TauT in taurine-treated CSAD KO was not restored. This difference may be attributed to differences in the amount of taurine used; CSAD KO and CDO KO were treated with 0.05 and 2 % in the drinking water, respectively (Ueki et al. 2011).
5 Conclusion
Newborn G3 HO and G4 HO mice with a milk spot (MS) survive and thrive to grow well as we demonstrated previously. Surviving CSAD KO at 1 M after weaning indicated that taurine is redistributed on the basis of need, regardless of its origin, which suggests that the requirement for taurine for homeostasis and survival may vary from organ to organ. Although CSAD KO has low reproductive performance, surviving CSAD KO mice are good models for understanding the physiological role of taurine in various disorders as well as for examining gene regulation in the absence of CSAD and/or low taurine levels. Supplementation of taurine in the food and drinking water may provide a potential prevention and treatment of various disorders caused by taurine deficiency, especially prior to or during pregnancy.
Abbreviations
- CSAD:
-
Cysteine sulfinic acid decarboxylase
- CSAD KO:
-
Cysteine sulfinic acid decarboxylase knockout mice
- CDO:
-
Cysteine dioxygenase
- CDO KO:
-
Cysteine dioxygenase knockout mice
- ADO:
-
Cysteamine (2-aminoenthanethiol) dioxygenase
- WT:
-
Wild type (CSAD+/+)
- HT:
-
Heterozygotic mice (CSAD+/−)
- HO:
-
Homozygotic mice (CSAD−/−)
- HOT:
-
Homozygotic mice treated with 0.05 % taurine
- TauT:
-
Taurine transporter
- TauT KO:
-
Taurine transporter knockout mice
- Gpx 1:
-
Glutathione peroxidase 1
- Gpx 3:
-
Glutathione peroxidase 3
- Prdx 2:
-
Peroxireductase 2
- Prdx 3:
-
Peroxireductase 3
- Prlr:
-
Prolactin receptor
- Ltf:
-
Lactoferrin
- Upp 2:
-
Uridine phosphorylase 2
- Sds:
-
Serine dehydratase
- G1 G2, G3, G4:
-
Generation 1, 2, 3 and 4
- G1 HO:
-
HO (CSAD−/−) mice born from HT (CSAD+/−) parents
- G2 or G3 HO:
-
Mice born from G1 HO or G2 HO parents
References
Battaglia A, Bortoluzza A, Galbucci F, Eusebi V, Giorgianni P, Ricci R, Tosi R, Tugnoli V (1999) High performance liquid chromatographic analysis of physiological amino acids in human brain tumor by pre-column derivatization with phenylisothiocyanate. J Chromatogr B Biomed Sci Appl 730:81–93
Bella DL, Kwon YH, Hirschberger LL, Stipanuk MH (2000) Post-transcriptional regulation of cysteine dioxygenase in rat liver. Adv Exp Med Biol 483:71–85
Binart N, Bachelot A, Bouilly J (2010) Impact of prolactin receptor isoforms on reproduction. Trends Endocrinol Metab 21:362–368
Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19(3):225–268
Bonhaous DW, Pasantes-Morales H, Huxtable RJ (1985) Actions of guanidinoethane sulfonate on taurine concentration, retinal morphology and seizure threshold in the neonatal rat. Neurochem Int 7:263–270
Brigelius-Flohe R, Maiorino M (2013) Glutathione peroxidases. Biochim Biophys Acta 1830(5):3289–3303
Brooks CL (2012) Molecular mechanisms of prolactin and its receptor. Endocr Rev 33(4):1–22
Dela Rosa J, Stipanuk MH (1984) Effect of guanidinoethanesulfonate administration on taurine levels in rat dams and their pups. Nutr Rep Int 30:1121–1125
Dominy JE, Simmons CR, Hirshberger LL, Hwang J, Coloso RM, Stipanuk MH (2007) Discovery and characterization of a second mammalian thiol dioxygenase, cysteamine dioxygenase. J Biol Chem 282:25189–25251
Grillo MA, Lanza A, Colombatto S (2008) Transport of amino acids through the placenta and their role. Amino Acids 34(4):517–523
Heller-Stilb B, van Royen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U, Haeussinger D (2002) Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 16:231–233
Hosokawa Y, Matumoto A, Oka J, Itakura H, Yamaguchi K (1990) Isolation and characterization of a complementary DNA for rat liver cysteine dioxygenase. Biochem Biophys Res Commun 168:473–478
Huxtable RJ (2000) Expanding the Circle 1975–1999: sulfur biochemistry and insights on the biological functions of taurine. Adv Exp Med Biol 483:1–25
Imai S, Kanamoto R, Yagi I, Kotaru M, Saeki T, Iwami K (2003) Response of the induction of rat liver serine dehydratase to changes in the dietary protein requirement. Biosci Biotechnol Biochem 67(2):383–387
Ishikawa E, Ninagawa T, Suda M (1965) Hormonal and dietary control of serine dehydratase in rat liver. J Biochem 57(4):506–513
Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927–937
Johansson M (2003) Identification of a novel human uridine phosphorylase. Biochem Biophys Res Commun 307:41–46
Jong CJ, Ito T, Mozaffari M, Azuma J, Schaffer S (2010) Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content. J Biomed Sci 17(Suppl 1):S25. doi:10.1186/1423-0127-17-S1-S25
Legrand D (2012) Lactoferrin, a key molecule in immune and inflammatory processes. Biochem Cell Biol 90(3):252–268
Legrand D, Mazurier J (2010) A critical review of the roles of host lactoferrin in immunity. Biometals 23(3):365–376
Lopez-Flores I, Peragon J, Valderraa R, Esteban FJ, Luque F, Peinado MA, Aranda F, Lupianez JA, Barroso JB (2006) Down-regulation in the expression of the serine dehydratase in the rat liver during chronic metabolic acidosis. Am J Physiol Regul Integr Comp Physiol 291(5):R295–R302
Lubos E, Loscalzo J, Handy DE (2011) Glutathione peroxidase-1 in health and disease: from molecular mechanism to therapeutic opportunities. Antioxid Redox Signal 15(7):1957–1997
Masuda T, Ogawa H, Matsushima T, Kawamata S, Sasahara M, Kuroda K, Suzuki Y, Takata Y, Ymazaki M, Takusagawa F, Pitot HC (2003) Localization and hormonal control of serine dehydratase during metabolic acidosis differ markedly from those of phosphoenolpyruvate carboxykinase in rat kidney. Int J Biochem Cell Biol 35(8):1234–1247
Park E, Park SY, Wang C, Xu J, LaFauci G, Schuller-Levis G (2002) Cloning of murine cysteine sulfinic acid decarboxylase and its mRNA expression in murine tissues. Biochim Biophys Acta 1574:403–406
Park E, Park SY, Dobkin C, Schuller-Levis G (2014) Development of a novel cysteine sulfinic acid decarboxylase knockout mouse: dietary taurine reduces neonatal mortality. J Amino Acids Article ID 346809, 1–11
Roman HB, Hirschberger LL, Krijt J, Valli A, Kozich V, Stipanuk MH (2013) The cysteine dioxygenase knockout mouse: altered cysteine metabolism in nonhepatic tissues leads to excess H2S/HS- production and evidence of pancreatic and lung toxicity. Antioxid Redox Signal. doi:10.1089/ars.2012.5010
Roosild TP, Castronovo S, Villoso A, Ziemba A, Pizzorno G (2011) A novel structural mechanism for redox regulation of uridine phosphorylase 2 activity. J Struct Biol 176(2):229–237
Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87(2):91–99
Schuller-Levis G, Park E (2006) Is taurine a biomarker? Adv Clin Chem 41:1–21
Stipanuk MH (2004) Role of the liver in regulation of body cysteine and taurine levels: a brief review. Neurochem Res 29:105–110
Sturman JA (1993) Taurine in development. Physiol Rev 73:119–146
Sturman JA, Messing JM (1991) Dietary taurine content and feline production and outcome. J Nutr 121:1195–1203
Sturman JA, Messing JM (1992) High dietary taurine effects on feline tissue taurine concentrations and reproductive performance. J Nutr 122:82–88
Uchida S, Kwon HM, Yamauchi A, Preston AS, Marumo F, Handler JS (1992) Molecular cloning of the cDNA for an MDCK cell Na(+)- and Cl (-)-dependent taurine transporter that is regulated by hypertonicity. Proc Natl Acad Sci U S A 89:8230–8234
Ueki I, Roman HB, Valli A, Fieselmann K, Lam J, Peters R, Hirschberger LL, Stipanuk MH (2011) Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. Am J Physiol Endocrinol Metab 301:E668–E684
Ueki I, Roman HB, Hirschberger LL, Junior C, Stipanuk MH (2012) Extrahepatic tissues compensate for loss of hepatic taurine synthesis in mice with liver-specific knockout of cysteine dioxygenase. Am J Physiol Endocrinol Metab 302:E1292–E1299
Wan L, Cao D, Zeng J, Ziemba A, Pizzorno G (2010) Activation of Stat1, IRF-1 and NF-kappaB is required for the induction of uridine phosphorylase by tumor necrosis factor-alpha and interferon-gamma. Nucleosides Nucleotides Nucleic Acids 29(4–6):488–503
Ward PP, Conneely OM (2004) Lactoferrin: role in iron homeostasis and host defense against microbial infection. Biometals 17(4):204–208
Warsulat U, Heller-Stilb B, Oermann E, Zilles K, Haas H, Lang F, Haessinger D (2007) Phenotype of the taurine transporter knockout mouse. Methods Enzymol 428:439–458
Acknowledgements
This work was supported by the Office for People with Developmental Disabilities, Albany, NY and Dong A Pharmaceutical Co., LTD, Seoul, Korea. We are thankful to Drs. John Sturman and William Levis for discussing the research and reviewing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Park, E., Park, S.Y., Dobkin, C., Schuller-Levis, G. (2015). A Novel Cysteine Sulfinic Acid Decarboxylase Knock-Out Mouse: Comparison Between Newborn and Weanling Mice. In: Marcinkiewicz, J., Schaffer, S. (eds) Taurine 9. Advances in Experimental Medicine and Biology, vol 803. Springer, Cham. https://doi.org/10.1007/978-3-319-15126-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-15126-7_1
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15125-0
Online ISBN: 978-3-319-15126-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)